Question 1

Does AQR Capital Management own SAVA stock?

Accepted Answer

No. AQR Capital Management exited its SAVA (Filana Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 29,782 shares worth $53,905.

Question 2

How many shares of SAVA does AQR Capital Management own?

Accepted Answer

None since Q3 2025, when AQR Capital Management exited the position. Its Q2 2025 13F listed 29,782 shares worth $53,905.

Question 3

What is AQR Capital Management's SAVA position worth?

Accepted Answer

AQR Capital Management's SAVA position was worth $53,905 in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is AQR Capital Management buying or selling SAVA?

Accepted Answer

In Q3 2025, AQR Capital Management exited its entire SAVA position.

Question 5

When did AQR Capital Management first buy SAVA?

Accepted Answer

AQR Capital Management first reported SAVA in its Q3 2020 13F and listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$2.91	0
2025-Q2	Decreased	29,782	-62.8%	$53,905	0.0%	$1.81	0
2025-Q1	New	79,944	—	$119,917	0.0%	$1.50	30